Ann Colosia
YOU?
Author Swipe
View article: Clinical Spectrum and Dynamics of Sequelae Following Tick-Borne Encephalitis Virus Infection: A Systematic Literature Review
Clinical Spectrum and Dynamics of Sequelae Following Tick-Borne Encephalitis Virus Infection: A Systematic Literature Review Open
Background Infection with the tick-borne encephalitis virus (TBEV) can affect the nervous system and lead to significant morbidity. To summarize current knowledge of long-term outcomes following TBEV infection, we systematically reviewed t…
View article: A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection
A Systematic Literature Review of the Epidemiology of Complicated Urinary Tract Infection Open
View article: P-1563. Assessing the Global Economic Burden of Complicated Urinary Tract Infections
P-1563. Assessing the Global Economic Burden of Complicated Urinary Tract Infections Open
Background Complicated urinary tract infections (cUTIs) arise in patients with structural or functional abnormalities of the genitourinary tract or in those with nonurogenital comorbidities. cUTIs are common in older or catheterized person…
View article: Clinical manifestations and outcomes of Tick-borne encephalitis: A systematic literature review
Clinical manifestations and outcomes of Tick-borne encephalitis: A systematic literature review Open
Tick-borne encephalitis (TBE) is caused by a viral infection and can lead to acute and persistent damage to the central and peripheral nervous systems. Recently, the incidence of TBE in Europe has risen, and epidemiological patterns of dis…
View article: Economic burden of respiratory syncytial virus infection in adults: a systematic literature review
Economic burden of respiratory syncytial virus infection in adults: a systematic literature review Open
Despite several data gaps, the economic burden of RSV infections on healthcare systems and payers was found to be substantial, globally, underscoring the need for RSV preventive strategies for reducing this burden.
View article: Systematic literature review of the signs and symptoms of respiratory syncytial virus
Systematic literature review of the signs and symptoms of respiratory syncytial virus Open
Respiratory syncytial virus (RSV) is responsible for over 30 million lower respiratory tract infections (LRTIs) and 3 million hospitalizations worldwide each year. Despite the risk RSV poses to young children, older adults, and individuals…
View article: The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review
The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review Open
Ann Colosia,1 Annete Njue,2 Zahid Bajwa,3 Erika Dragon,4 Rebecca L Robinson,5 Kristin M Sheffield,5 Sheena Thakkar,6 Steven H Richiemer7 1Department of Market Access and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, …
View article: The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review
The Burden of Metastatic Cancer–Induced Bone Pain: A Narrative Review Open
Bone pain is one of the most common forms of pain reported by cancer patients with metastatic disease. We conducted a review of oncology literature to further understand the epidemiology of and treatment approaches for metastatic cancer-in…
View article: The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review
The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: A systematic review Open
Protection of older adults against RSV could reduce respiratory-related burden, especially as age increases and the prevalence of comorbidities (especially cardiopulmonary comorbidities) grows.
View article: Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis Open
Background: Palbociclib is the first cyclin-dependent kinase 4/6 inhibitor approved in the United States for HR+/HER2- advanced/metastatic breast cancer, in combination with letrozole as initial endocrine-based therapy in postmenopa…
View article: A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma
A Systematic Literature Review of Adverse Events Associated with Systemic Treatments Used in Advanced Soft Tissue Sarcoma Open
This systematic literature review describes adverse events (AEs) among patients with soft tissue sarcoma (STS) who received second-line or later anticancer therapies. Searches were conducted in PubMed, EMBASE, and Cochrane Central Register…